In today’s video, I’ll break down Oklo (NASDAQ: OKLO) — the nuclear energy company behind one of 2025’s biggest stock rallies, soaring more than 1,400% over the last 12 months.
1 extracted signal · 1 resolved · 0 still active
Rick Orford - Trading Stocks and Options For AllIndependent analyst profile- Source published
- 20 Oct 2025, 21:00 UTC
- Recorded by Tahlil Plus
- 18 May 2026, 20:23 UTC

AI-generated source summary
Oklo Inc. is a nuclear technology company that designs and operates advanced fission reactors. Their 'Aurora powerhouse' product line aims to provide clean, reliable, and affordable energy by utilizing recycled nuclear waste. While the company is experiencing ongoing losses, its balance sheet shows strong liquidity with a current ratio of 71.2, indicating a good position to meet short-term obligations and fund new projects. Despite the losses, analysts maintain a 'moderate buy' rating with a target price suggesting significant upside potential. The market seems to view Oklo as a patient, long-term play rather than a momentum trade, awaiting the successful deployment of its reactors.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
Rick Orford - Trading Stocks and Options For All
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.
